Virtual basket mode in HoLEP: reduced early dysuria and faster continence recovery without loss of efficacy
Abstract
OBJECTIVES
Holmium laser enucleation of the prostate (HoLEP) is an established treatment for benign prostatic hyperplasia (BPH), but early postoperative dysuria and incontinence remain common concerns. The Virtual Basket (VB) mode has been proposed to reduce tissue trauma. This study evaluated whether VB use improves early postoperative recovery without compromising HoLEP efficacy.
METHODS
We retrospectively analyzed 168 men who underwent HoLEP between September 2023 and September 2024. Patients were categorized into three groups according to laser settings: 100 W Standard (n = 65), 100 W VB (n = 49), and 80 W VB (n = 54). The primary outcomes were postoperative dysuria and urinary incontinence at 1 and 3 months. Secondary outcomes included catheterization time, hemoglobin drop, surgical and energy efficiency, and perioperative complications. Logistic regression and receiver operating characteristic (ROC) analyses were performed to identify predictors of persistent incontinence.
RESULTS
At 1 month, dysuria occurred more frequently in the Standard group (32.3%) than in the VB groups (15.6%) (p = 0.037). This difference was resolved within 3 months. Persistent urinary incontinence at 3 months was significantly lower in the VB groups (2.0% and 1.9%) compared with the Standard group (9.2%) (p = 0.031). Surgical efficiency was higher with Standard HoLEP (2.63 g/min vs. 1.8 g/min, p = 0.035), while energy efficiency was comparable across groups. The 100 W VB group had shorter…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.